Compare ARBB & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARBB | PFSA |
|---|---|---|
| Founded | 1997 | 2009 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 8.9M |
| IPO Year | 2023 | N/A |
| Metric | ARBB | PFSA |
|---|---|---|
| Price | $5.51 | $0.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 26.2K | ★ 14.6M |
| Earning Date | 11-03-2025 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $46,842,655.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $24.79 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 239.12 | 122.22 |
| 52 Week Low | $3.92 | $0.05 |
| 52 Week High | $18.60 | $12.76 |
| Indicator | ARBB | PFSA |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 31.07 |
| Support Level | $5.72 | $0.08 |
| Resistance Level | $7.34 | $0.10 |
| Average True Range (ATR) | 0.40 | 0.02 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 2.86 | 2.28 |
ARB IOT Group Ltd is a provider of complete solutions to the clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. The company offers a wide range of IoT systems as well as provides customers with a substantial range of services such as system integration and system support services. It delivers solutions like designing, installation, testing and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company operates in two reportable segments: (i) the provision of hardware and software of IoT solutions and (ii) Investment holding and others. The majority of revenue is generated from the IoT solutions segment.
Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.